Mary Tyler Arminio, | |
2450 Village Professional Dr N, Opelika, AL 36801-4734 | |
(334) 528-1964 | |
Not Available |
Full Name | Mary Tyler Arminio |
---|---|
Gender | Female |
Speciality | Physical Medicine & Rehabilitation |
Location | 2450 Village Professional Dr N, Opelika, Alabama |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1710755954 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208100000X | Physical Medicine & Rehabilitation | 4424 (Alabama) | Primary |
Entity Name | Rehabworks Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1114573995 PECOS PAC ID: 3375975204 Enrollment ID: O20191115000005 |
News Archive
The last few years have seen a puzzling and welcome new trend in health care spending: Instead of going up and up, increases have slowed way down.
Curcumin, the main component in the spice turmeric, suppresses a cell signaling pathway that drives the growth of head and neck cancer, according to a pilot study using human saliva by researchers at UCLA's Jonsson Comprehensive Cancer Center.
PaxVax Inc, which develops and commercializes innovative vaccines against infectious diseases in a socially responsible manner, today announced that it has commenced its Phase 3 clinical trial program for its single-dose oral cholera vaccine candidate, PXVX0200 (also known as CVD 103-HgR). Approximately 3,000 participants will be enrolled in this pivotal program, which is comprised of cholera challenge, safety, and immunogenicity studies.
To the tantalizing delight of chocolate lovers everywhere, a number of recent studies employing various methods have suggested that compounds in cocoa called flavanols could benefit cardiovascular health.
Osteopore International Pte Ltd, a Singapore-headquartered company leading the way in regenerative bone implants, is proud to announce the success of its technology in a new medical procedure that took place in Brisbane, Australia, in December last year.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Mary Tyler Arminio, 2450 Village Professional Dr N, Opelika, AL 36801-4734 Ph: (334) 528-1964 | Mary Tyler Arminio, 2450 Village Professional Dr N, Opelika, AL 36801-4734 Ph: (334) 528-1964 |
News Archive
The last few years have seen a puzzling and welcome new trend in health care spending: Instead of going up and up, increases have slowed way down.
Curcumin, the main component in the spice turmeric, suppresses a cell signaling pathway that drives the growth of head and neck cancer, according to a pilot study using human saliva by researchers at UCLA's Jonsson Comprehensive Cancer Center.
PaxVax Inc, which develops and commercializes innovative vaccines against infectious diseases in a socially responsible manner, today announced that it has commenced its Phase 3 clinical trial program for its single-dose oral cholera vaccine candidate, PXVX0200 (also known as CVD 103-HgR). Approximately 3,000 participants will be enrolled in this pivotal program, which is comprised of cholera challenge, safety, and immunogenicity studies.
To the tantalizing delight of chocolate lovers everywhere, a number of recent studies employing various methods have suggested that compounds in cocoa called flavanols could benefit cardiovascular health.
Osteopore International Pte Ltd, a Singapore-headquartered company leading the way in regenerative bone implants, is proud to announce the success of its technology in a new medical procedure that took place in Brisbane, Australia, in December last year.
› Verified 9 days ago
Sarah Klein, Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2701 Frederick Rd Ste 306, Opelika, AL 36801 Phone: 334-610-0354 | |
Dr. Rita L Harvey, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2200 Gateway Dr Ste A, Opelika, AL 36801 Phone: 334-745-5200 Fax: 334-737-2091 |